Copy number variation in development disorders, malformative syndrome and short stature in Peru
- Hugo H. Abarca Barriga(corresponding author),
- Flor de Milagros Vásquez Sotomayor,
- Milana Trubnykova,
- Félix Chavesta Velásquez,
- Miguel A. Chávez Pastor,
- Bertha E. Gallardo Jugo
- ,
- Instituto Nacional de Salud del Niño,
- Universidad Peruana Cayetano Heredia,
- GenoCenter
Open access
Publication Information
Output type
Original language
SpanishPages from-to (Number of pages)
Pages 145-155 (11 pages)Journal (Volume, Issue Number)
Acta Medica Peruana (Volume 37, Issue 2)Publication milestones
- Published - 14/05/2020
Publication status
ISSN
1018-8800Publication IDs
- Scopus: 85152145115
Abstract
Objective: To establish the ratios of the copy number variations and regions of homozygosity through chromosomal microarray analysis (CMA) in children with neurodevelopmental disorders: development delay (DD), intellectual disability (ID), and/or autistic spectrum disorder (ASD), malformative syndrome (MS) and idiopathic short stature (ISS). Materials and Methods: We evaluated 367 Peruvian children diagnosed clinically with ID, DD, ASD, ISS and MS to whom performed chromosomal microarray analysis in peripheral blood (750K CGH + SNP), between the years 2016-2018. Results: Patients' age fluctuated between 4.8 months and 18 years old, with an average of 5.6 years old. The most frequent diagnoses were development delay (48%) and intellectual disability (30%). Abnormal results (pathogenic variants, likely pathogenic variants, uniparental disomies and loss of heterozygosity> 2.5%) were reported in 50.3%. The 53.28% of the cases with a diagnosis of intellectual disability and 47.92% of development delay showed abnormal results; while the children with short stature syndromic, malformative syndrome, and autistic disorders spectrum disorders showed abnormal results in 52.38%, 52% and 20% respectively. Additionally, we found that 6.25% of parents were non-declared consanguinity. Conclusions: Abnormal results found in our study was a higher ratio than other international reports regardless of the clinical diagnosis. Furthermore, we show a most rate of non-declared consanguinity in relation with previous reports.
